Moderna
MRNA
#1154
Rank
A$28.02 B
Marketcap
A$70.67
Share price
0.37%
Change (1 day)
65.30%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Annual Reports (10-K)

Latest form 10-K annual reports for Moderna CIK: 0001682852

Thumbnail Moderna
 10-K Annual Report

10-K Annual Report 2026-02-20

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report

10-K Annual Report 2025-02-21

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report

10-K Annual Report 2024-02-23

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report

10-K Annual Report 2023-02-24

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report

10-K Annual Report 2022-02-25

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report

10-K Annual Report 2021-02-26

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report

10-K Annual Report 2020-02-27

Language: English

View Annual Report (10-K)
Thumbnail Moderna
 10-K Annual Report

10-K Annual Report 2019-03-13

Language: English

View Annual Report (10-K)